(Q46489982)

22 December 2017

title

Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV. (English)

1 reference

22 December 2017

author name string

Reiichiro Kuwahara

1

1 reference

22 December 2017

Ryukichi Kumashiro

2

1 reference

22 December 2017

Tatsuya Ide

3

1 reference

22 December 2017

Yuriko Koga

4

1 reference

22 December 2017

Teruko Hino

5

1 reference

22 December 2017

Akiko Hisamochi

6

1 reference

22 December 2017

Kazuo Tanaka

7

1 reference

22 December 2017

Kei Ogata

8

1 reference

22 December 2017

Hiroyuki Koga

9

1 reference

22 December 2017

Yukari Takao

10

1 reference

22 December 2017

Michio Sata

11

1 reference

22 December 2017

publication date

10 July 2008

1 reference

22 December 2017

Digestive Diseases and Sciences

published in

1 reference

22 December 2017

volume

53

1 reference

22 December 2017

issue

11

1 reference

22 December 2017

page(s)

2999-3006

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s10620-008-0384-x

exact match

0 references

cites work

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

12 December 2020

Noninvasive diagnosis of hepatic fibrosis or cirrhosis

1 reference

12 December 2020

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

12 December 2020

Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.

1 reference

12 December 2020

Hepatitis B virus infection

1 reference

12 December 2020

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

1 reference

12 December 2020

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

1 reference

12 December 2020

The synthesis rates of total liver protein and plasma albumin determined simultaneously in vivo in humans.

1 reference

12 December 2020

Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis

1 reference

12 December 2020

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

1 reference

12 December 2020

Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B

1 reference

12 December 2020

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

1 reference

12 December 2020

Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis

1 reference

12 December 2020

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

12 December 2020

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

1 reference

12 December 2020

Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.

1 reference

12 December 2020

Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus

1 reference

12 December 2020

Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort

1 reference

12 December 2020

Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo

1 reference

12 December 2020

Long-term follow-up of chronic hepatitis B patients treated with interferon alfa

1 reference

12 December 2020

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

12 December 2020

Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection

1 reference

12 December 2020

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

1 reference

12 December 2020

Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

1 reference

12 December 2020

Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection

1 reference

12 December 2020

Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B.

1 reference

12 December 2020

Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy.

1 reference

12 December 2020

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

12 December 2020

Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver

1 reference

12 December 2020

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

12 December 2020

Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis

1 reference

12 December 2020

Histological outcome during long-term lamivudine therapy.

1 reference

12 December 2020

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

1 reference

12 December 2020

Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection

1 reference

12 December 2020

Acute liver failure during lamivudine treatment in a hepatitis B cirrhotic patient

1 reference

12 December 2020

Progressive liver functional impairment is associated with an increase in AST/ALT ratio.

1 reference

12 December 2020

Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1.

1 reference

12 December 2020

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

1 reference

12 December 2020

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa

1 reference

12 December 2020

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine

1 reference

12 December 2020

Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains

1 reference

12 December 2020

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

12 December 2020

YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection

1 reference

12 December 2020

Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors

1 reference

12 December 2020

10.1007/S10620-008-0384-X

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017